Insight

fitness

Fitness App Market 2020 provides an in-depth insight of Sales and Trends Forecast to 2026

The MarketWatch News Department was not involved in the creation of this content.

Dec 01, 2020 (AmericaNewsHour) —
The Global fitness app market size is anticipated to reach over USD 14.7 billion by 2026, according to a new study published by Polaris Market Research. In 2017, the fitness and activity tracking segment dominated the market, in terms of revenue. North America is expected to be the leading contributor to the global fitness app industry during the forecast period.
A significant increase in the obese population, changing lifestyles, and increasing health concerns primarily drive the market growth. Other driving factors include increasing occurrence of diseases associated with obesity, increasing disposable income, and increasing awareness regarding health and nutrition. The increase in obesity related diseases such as diabetes and hypertension along with sedentary lifestyles of consumers further propel the market growth.

Download Sample of This Strategic Report:- https://www.kennethresearch.com/sample-request-10070828

The number of memberships for health clubs and gyms has increased significantly over the years, further promoting the growth of fitness app industry. Increasing demand in developing nations, increasing penetration of mobile devices, and availability of high-speed internet services is expected provide numerous growth opportunities to the fitness app industry players during the forecast period.

A few major fitness apps available in the market include Runtastic Results, Calorie Counter & Diet Tracker, and Sweat, Kayla Itsines Fitness among others. Runtastic Results: Workout & Strength Training is offered by the Austrian company Runtastic. As part of the primary marketing strategy in fitness app industry, the company offers a wide range of portfolio with 20 different mobile apps running on all platforms. Runtastic was bought by Adidas in 2015 to increase its market share in the global fitness market industry. Sweat: Kayla Itsines Fitness is an app offered by The Bikini Body Training Company. This app provides nutrition recommendations and a series of aerobic exercises in the Bikini Body Guide (BBG) to practice at home.

In regards with the global fitness app market share, North America was in the forefront followed by Asia Pacific and Europe. The increasing population in the region coupled with high disposable income drives the market growth. The sedentary lifestyle of consumers in the region has encouraged them to adopt fitness apps to stay healthy and acquire proper nutrition. Asia-Pacific is expected to grow at the highest rate during the forecast period. Increasing disposable incomes in developing countries of this region, rising awareness and increasing health consciousness, growing presence of fitness centres, and growing penetration of smartphones further foster the growth of the fitness app industry in this region.

The key companies profiled in the report fitness app market analysis includes MyFitnessPal Inc., Dom and Tom Tom, Motorola Mobility LLC, Grandapps, Fitbit, Azumio, WillowTree, Inc., ASICS, Under Armour, and Appster among others. These companies launch new products and collaborate with other market leaders bringing innovation to meet the increasing demand of consumers.

Polaris Market Research has segmented the global fitness app market on the basis of type, platform, deployment, gender, and

Read More
medicine

Precision Medicine Market: Emerging Trends, Growth Insight, Comprehensive Insights, Rising Demand, Industry Trends & Revenue Models, 2027

The MarketWatch News Department was not involved in the creation of this content.

New York, United States, Wed, 11 Nov 2020 05:23:43 / Comserve Inc. / — The global precision medicine market can be segmented on the basis of product, technology, sequencing technology, application, end user and region.

Recent report published by research nester titled “Precision Medicine Market: Global Demand Analysis & Opportunity Outlook 2027″delivers the detailed overview of the global precision medicine market in terms of market segmentation by product, by technology, by sequencing technology, by application, by end user and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

The global precision medicine market can be segmented on the basis of product, technology, sequencing technology, application, end user and region. On the basis of product, it is sub-segmented into instruments, consumables and services. Based on technology, it is sub-segmented into transcriptomics, genomics and epigenomics. On the basis of sequencing technology, it is sub-segmented into ion semiconductor sequencing, pyrosequencing, single molecule real time Sequencing, chain termination sequencing, sequencing by synthesis, sequencing by ligation and nanopore sequencing. CLICK TO DOWNLOAD SAMPLE

Based on application, it is sub-segmented into immunology, CNS, oncology, respiratory medicine, infections and others. On the basis of end user, it is sub-segmented into pharma & biotech companies, diagnostic tool companies, big data companies and clinical laboratories. The market across the globe is exclusively focusing to provide specific tailored treatments to patients are also concentrating on proving the best possible treatment for cancer patients. These factors are anticipated to boost the growth of the global precision medicine market in upcoming years.

The global precision medicine market is anticipated to expand at a CAGR around 10.6% during 2019-2027. Increment in the growth of personal healthcare devices along with rise in investment in the research and development is expected to augment the market shares. Further, the rapid development in the field of bioinformatics combined with high adoption rate of gene therapy are some of the significant factors that are estimated to positively affect the growth of the market.

By region, the global precision medicine market is segmented into North America, Asia-Pacific, Latin America, Europe, Middle East and Africa. Among these region, North America is expected to dominate the global market of precision medicine on account of increasing cases related to rare genetic disorders and various initiatives taken by the regulatory bodies in support of the market. Further, the rising investment in the research and development in the field of precision medicine coupled with rising healthcare infrastructure are some of the factors that are augmenting the growth of market in this region. In the Europe region, Germany is expected to have the largest market share on the back of rising pediatric and adult population susceptible to metabolic diseases. Additionally, rising investment in the healthcare sector by various private and government organizations coupled with various technological advancements in this field is anticipated to

Read More
health

Global Oncolytic Virus Therapy Market 2026 Companies Clinical Trials Insight

Oncolytic Virus Immunotherapy Market Offers US$ 700 Million Opportunity With More Than 125 therapies in Clinical Trials says Kuick Research

DELHI, India, Nov. 02, 2020 (GLOBE NEWSWIRE) — “Global Oncolytic Virus Immunotherapy Market, Dosage, Price & Clinical Trials Outlook 2026” Report Highlights:

  • Global Oncolytic Virus Immunotherapy Market: US$ 700 Million Opportunity

  • Global Oncolytic Virus Immunotherapy Clinical Trials: >125 Therapies In Trials

  • USA Dominates Oncolytic Virus Immunotherapy Clinical Trials: >50 Therapies In Trials

  • Comprehensive Insight on Clinical & Non Clinical Issues Related to Global Oncolytic Virus Immunotherapy Market Development

  • Approved Oncolytic Virus Immunotherapy: 2

  • Global Research Progress & Medical Advancement Insight

  • Imlygic (Talimogene laherparepvec) & Oncorine: Dosage, Price & Patent insight

Download Report: https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-size-sales-clinical-trials-cancer-oncology-melanoma-report-talimogene-laherparepvec-imlygic–oncorine

Recent breakthrough with respect to oncolytic virus therapy in the oncology pharmaceutical industry has set up remarkable achievements in terms of understanding all the important proposed hallmarks for counteracting cancer mechanism of action. The important clinical management terms related with oncolytic virus therapy is believed to be extracting and abolishing all the disadvantages and limitations that were associated with all the commercially available cancer therapies. Certain challenges that were residing in the oncology pharmaceutical industry is estimated to end once the market associated with oncolytic virus therapy comes into full power in terms of financial and commercial availability.

The wide range applications of oncolytic virus therapy with respect to different types of cancers such as melanoma, prostate cancer, breast cancer, ovarian cancer and many others is estimated to deliver a very bulk amount of research and development investment for the future progress of the therapy at global level. The estimated future market competition oncolytic virus therapy is intense as the market is associated with some of the leading drug research and development players, high research marketing as well as a monopoly situation in treating different types of cancers. As per the study conducted for the market, it is estimated that in the next few years, the market will surpass USD 700 Million by 2026.

In a short period of time, oncolytic virus therapy has selectively replaced all the other traditional cancer therapies available for the cancer patients as the therapy is adjoined with large number of innovative principles. Several therapeutic agents under oncolytic virus therapy has entered clinical studies and have specifically proven to be safe and efficient for human use. Although the market is few years old but the related research and development sector as well as future research is believed to make the system functional as well as effective for millions of cancer patients who have been suffering very badly from past few years.

With the arrival of oncolytic virus therapy for the cancer patients, all the barriers that were pursed in the oncology pharmaceutical industry have been overcome promisingly as the therapy has entered and been recognized as a mainstream treatment facility for the clinical management of the cancer cells. The long-term future of the market at global level appears to be developing at a rate that is highly advanced as researchers

Read More
medicine

Hestia Insight Inc. Begins Healthcare Operations; Treating Anxiety, Depression; Exploring Alternate Medicine

Las Vegas, NV – ( NewMediaWire ) – October 22, 2020 – Hestia Insight Inc. (OTC: HSTA) new subsidiary, HSTA Health Inc. (HHI), today announced that it has entered a business partnership with Noether Sciences and Technologies, Inc.   HHI will utilize Noether’s IP therapy to treat anxiety and depression and has licensing rights for the therapy throughout the U.S.

“These two most common diseases cause numerous societal problems.  We believe this innovative technology will provide excellent healthcare services and we look forward to marketing it to medical professionals,” said Edward C. Lee, Chairman and President of Hestia and President of HHI.

“We are coming out of a difficult period, with the COVID-19 pandemic, and we believe there are many innovative technologies that should be introduced in the healthcare industry and commercialized,” Mr. Lee said.  “For instance, the alternative medicine market size, a multi-billion-dollar sector, continues to grow.  This includes yoga, meditation, magnetic intervention, acupuncture, and other wellness treatments.  HHI will work to lead and expand this sector.  We are exploring the establishments of clinics throughout the U.S. to provide better patient healthcare.”

Mr. Lee also stressed that:  “Healthcare companies with great products and technology have not been able to enter the marketplace in an effective way, often being unaware on how to communicate with healthcare industry professionals.  We look forward to assisting in this effort, a huge opportunity in a new dimension to make a better life for everyone.”

“After COVID-19 we believe consumers are ready to adapt to a new healthcare ecosystem. It will bring more hope to consumers,” concluded Mr. Lee. “The global healthcare market reached a value of nearly $8,452 billion in 2018, having grown at a compound annual growth rate (CAGR) of 7.3% since 2014, and is expected to grow at a CAGR of 8.9% to nearly $11,909 billion by 2022.”

ABOUT HESTIA INSIGHT INC.:  (www.hestiainsight.com) Hestia Insight Inc. is an advisory Company focused primarily on the great Healthcare and Biotech sectors. It also provides seed capital and mezzanine financing to its clients. Hestia Insight will make strategic acquisitions and mergers or joint ventures with emerging growth companies with intellectual properties. It provides sales and marketing guidance and capital market advice to increase the success of its clients.

(“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This press release contains or may contain forward-looking statements such as statements regarding the Company’s growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.)

Contact: Paul Knopick

[email protected]

940.262.3584

Source Article

Read More